Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

240 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world insights into risk of developing cardiovascular disease following GnRH agonists versus antagonists for prostate cancer: a methodological protocol to a study using five European databases.
George G, Scailteux LM, Garmo H, Balusson F, Cardwell C, Coster G, Schutter H, Kuiper JG, McMenamin Ú, Verbeeck J, Van Hemelrijck M. George G, et al. Among authors: verbeeck j. Fundam Clin Pharmacol. 2019 Aug;33(4):479-499. doi: 10.1111/fcp.12454. Epub 2019 Mar 25. Fundam Clin Pharmacol. 2019. PMID: 30776136 Free PMC article.
Risk of cardiovascular disease following gonadotropin-releasing hormone agonists vs antagonists in prostate cancer: Real-world evidence from five databases.
George G, Garmo H, Scailteux LM, Balusson F, De Coster G, De Schutter H, Kuiper JG, Oger E, Verbeeck J, Van Hemelrijck M. George G, et al. Among authors: verbeeck j. Int J Cancer. 2021 May 1;148(9):2203-2211. doi: 10.1002/ijc.33397. Epub 2020 Nov 23. Int J Cancer. 2021. PMID: 33186481 Free PMC article.
Comparative performance of a modified landmark approach when no time of treatment data are available within oncological databases: exemplary cohort study among resected pancreatic cancer patients.
Weberpals J, Jansen L, Silversmit G, Verbeeck J, van der Geest L, Vissers PA, Zadnik V, Brenner H. Weberpals J, et al. Among authors: verbeeck j. Clin Epidemiol. 2018 Aug 30;10:1109-1125. doi: 10.2147/CLEP.S160973. eCollection 2018. Clin Epidemiol. 2018. PMID: 30214315 Free PMC article.
One-year excess mortality and treatment in surgically treated patients with colorectal cancer: A EURECCA European comparison.
Bahadoer RR, Bastiaannet E, Claassen YHM, van der Mark M, van Eycken E, Verbeeck J, Guren MG, Kørner H, Martling A, Johansson R, van de Velde CJH, Dekker JWT. Bahadoer RR, et al. Among authors: verbeeck j. Eur J Surg Oncol. 2021 Jul;47(7):1651-1660. doi: 10.1016/j.ejso.2021.01.011. Epub 2021 Jan 21. Eur J Surg Oncol. 2021. PMID: 33518367 Free article.
The survival gap between young and older patients after surgical resection for colorectal cancer remains largely based on early mortality: A EURECCA comparison of four European countries.
Bahadoer RR, Bastiaannet E, Peeters KCMJ, van Eycken E, Verbeeck J, Guren MG, Kørner H, Martling A, Johansson R, van de Velde CJH, Dekker JWT. Bahadoer RR, et al. Among authors: verbeeck j. J Geriatr Oncol. 2022 Jul;13(6):803-812. doi: 10.1016/j.jgo.2022.04.011. Epub 2022 May 6. J Geriatr Oncol. 2022. PMID: 35527207 Free article.
Higher relative survival in breast cancer patients treated in certified and high-volume breast cancer centres - A population-based study in Belgium.
Leroy R, Silversmit G, Bourgeois J, De Gendt C, Savoye I, Verbeeck J, Van Damme N, Stordeur S, Canon JL, Carly B, Cusumano PG, de Azambuja E, De Visschere P, Decloedt J, Desreux J, Duhoux FP, Taylor D, van Dam P, Vanhoutte I, Veldeman L, Wildiers H. Leroy R, et al. Among authors: verbeeck j. Eur J Cancer. 2024 Oct;210:114232. doi: 10.1016/j.ejca.2024.114232. Epub 2024 Jul 20. Eur J Cancer. 2024. PMID: 39236426
240 results